Knee osteoarthritis
Conditions
Interventions
one:Jintiange and celecoxib
two:Jintiange Placebo and Celecoxib
Sponsors
The Second Affiliated Hospital Of Xi'an Jiaotong University
Eligibility
Sex/Gender
All
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Patients who meet the clinical diagnostic criteria for osteoarthritis of the knee. (2) Age 40-70 years old with no restriction on gender. (3) Body mass index (BMI) = 35 kg/m2 (4) Subject's KOA staging is in remission, recovery. (5) VAS score = 7. (6) Patients who have not undergone KOA systemic treatment within 3 months and who can adhere to the treatment schedule and can cooperate with clinical observation and follow-up. (7) Subjects understood and signed the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Traumatic arthritis of the knee joint; acute joint injury, osteoarthritic tuberculosis of the knee, tumors, rheumatoid arthritis, rheumatoid arthritis. (2) Patients who have undergone knee replacement. (3) Patients with combined cardiovascular, cerebrovascular, hepatic, renal and hematopoietic system and other serious primary diseases, tumors and psychiatric patients, neuropathic arthralgia, gastric ulcers. (4) Patients who have used drugs known to cause damage to major organs within 4 weeks. (5) Patients who are allergic to the drug components associated with this test. (6) Pregnant and lactating women. (7) Those who have taken herbal tonics, proprietary Chinese medicines or other western medicines for the treatment of osteoarthritis of the knee within the last two weeks (8) Patients who are unable to cooperate or are participating in other drug trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| WOMAC; | — |
Countries
China
Contacts
Public ContactWang Wei
The Second Affiliated Hospital Of Xi'an Jiaotong University
Outcome results
None listed